Skip to content

Flunoxaprofen

GENITO URINARY SYSTEM AND SEX HORMONES

Also known as: (S)-(+)-Flunoxaprofen, (S)-Flunoxaprofen

ATC G02CC04ATC M01AE15

Data last refreshed: (DrugCentral release 2024-11-01)

Key facts

Flunoxaprofen is a drug catalogued in DrugCentral. Recorded indications include Rheumatoid arthritis.

  • Indications: Rheumatoid arthritis.
  • ATC code: G02CC04 (Antiinflammatory products for vaginal administration).
  • Molecular formula: C16H12FNO3; molecular weight 285.27 g/mol.

Indications & contraindications

Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).

Indications (1)

  • Rheumatoid arthritis

ATC classification

ATC codeTherapeutic hierarchy
G02CC04GENITO URINARY SYSTEM AND SEX HORMONES › OTHER GYNECOLOGICALS › OTHER GYNECOLOGICALS › Antiinflammatory products for vaginal administration
M01AE15MUSCULO-SKELETAL SYSTEM › ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS › ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS › Propionic acid derivatives

Chemical structure

Molecular formulaC16H12FNO3
Molecular weight285.27 g/mol
CAS number66934-18-7
InChIKeyARPYQKTVRGFPIS-VIFPVBQESA-N
PubChem CID68869
C[C@H](C(O)=O)C1=CC2=C(OC(=N2)C2=CC=C(F)C=C2)C=C1

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

What is Flunoxaprofen used for?

DrugCentral lists the following indications for Flunoxaprofen: Rheumatoid arthritis.

What is the chemical formula of Flunoxaprofen?

Flunoxaprofen has the molecular formula C16H12FNO3 and a molecular weight of 285.27 g/mol.

Browse: all drugs starting with F · drug guides by category · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.

Quick facts

Status—
First approval—
Agency—
Targets0
Indications1
FormulaC16H12FNO3
DrugCentral ID1203
Interactive profile